We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.2B
AUM Growth
+$642M
Cap. Flow
-$66.7M
Cap. Flow %
-0.59%
Top 10 Hldgs %
52.34%
Holding
1,116
New
76
Increased
314
Reduced
582
Closed
97

Sector Composition

Rank Sector Weight
1 Energy 63.96%
2 Technology 5.43%
3 Healthcare 4.22%
4 Consumer Discretionary 3.76%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOLD
1051
DELISTED
Amicus Therapeutics
FOLD
-153,069
Closed -$1.6M
GNRC icon
1052
Generac Holdings
GNRC
$11.9B
-1,488
Closed -$265K
HII icon
1053
Huntington Ingalls Industries
HII
$11.3B
-104,851
Closed -$23.2M
HL icon
1054
Hecla Mining
HL
$10.2B
-358,656
Closed -$1.41M
HST icon
1055
Host Hotels & Resorts
HST
$16.8B
-10,019
Closed -$159K
IDYA icon
1056
IDEAYA Biosciences
IDYA
$3.41B
-21,409
Closed -$319K
ILPT
1057
Industrial Logistics Properties Trust
ILPT
$613M
-73,489
Closed -$404K
IONS icon
1058
Ionis Pharmaceuticals
IONS
$9.35B
-77,480
Closed -$3.43M
IOVA icon
1059
Iovance Biotherapeutics
IOVA
$2.23B
-86,118
Closed -$825K
IRWD icon
1060
Ironwood Pharmaceuticals
IRWD
$611M
-83,628
Closed -$866K
IVVD icon
1061
Invivyd
IVVD
$180M
-59,405
Closed -$186K
KALV
1062
DELISTED
KalVista Pharmaceuticals
KALV
-13,433
Closed -$195K
KRON
1063
DELISTED
Kronos Bio
KRON
-31,034
Closed -$104K
LBRDK icon
1064
Liberty Broadband Class C
LBRDK
$4.15B
-10,350
Closed -$764K
LGND icon
1065
Ligand Pharmaceuticals
LGND
$6.02B
-14,810
Closed -$796K
LTC
1066
LTC Properties
LTC
$2.16B
-11,779
Closed -$441K
MCRB icon
1067
Seres Therapeutics
MCRB
$48M
-3,389
Closed -$435K
MDXG icon
1068
MiMedx Group
MDXG
$626M
-62,007
Closed -$178K
MLTX icon
1069
MoonLake Immunotherapeutics
MLTX
$1.59B
-20,144
Closed -$160K
NHI icon
1070
National Health Investors
NHI
$3.9B
-7,886
Closed -$446K
NNN icon
1071
NNN REIT
NNN
$9.39B
-11,541
Closed -$460K
NTLA icon
1072
Intellia Therapeutics
NTLA
$1.5B
-41,521
Closed -$2.32M
NUVL
1073
DELISTED
Nuvalent
NUVL
-23,509
Closed -$457K
O icon
1074
Realty Income
O
$61.2B
-7,811
Closed -$455K
ORGO icon
1075
Organogenesis Holdings
ORGO
$308M
-71,410
Closed -$231K

Similar funds

ALPS Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, ALPS Advisors held 1,116 positions worth $11.2B, up 6.1% from $10.6B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors's Q4 2022 filing shows 76 new, 314 increased, 582 reduced and 97 closed positions. Its largest new stake was Albemarle: 124,308 shares worth $27M. The largest sale was Shell Midstream Partners, L.P., an estimated $280M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 63% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q4 2022 buy was Albemarle: 124,308 shares worth $27M.
  • ALPS Advisors added most to Crestwood Equity Partners LP in Q4 2022, an estimated $62.5M increase.
  • ALPS Advisors's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $28.2M.
  • ALPS Advisors fully exited Shell Midstream Partners, L.P. in Q4 2022, selling an estimated $280M.
  • ALPS Advisors's ten largest holdings make up 52% of its $11.2B portfolio in Q4 2022.
  • ALPS Advisors opened 76 new positions and closed 97 in Q4 2022.
  • ALPS Advisors's portfolio value rose 6.1% quarter-over-quarter to $11.2B.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.